Résumé
L’hémodialyse intermittente et la dialyse péritonéale représentaient l’essentiel des épurations extrarénales effectuées en réanimation jusque dans les années 1970. De nouvelles techniques d’épuration continue sont apparues et se sont progressivement imposées comme méthode thérapeutique pour la prise en charge de l’insuffisance rénale aiguë (1). Actuellement, l’hémofiltration continue (HFC), qui repose sur des échanges convectifs contrairement à l’hémodialyse qui fonctionne par un mécanisme diffusif, est la technique de suppléance rénale la plus utilisée en réanimation lors d’une agression rénale aiguë (ARA) classiquement appelée insuffisance rénale aiguë. Cependant, le choix entre les deux techniques repose essentiellement sur des préférences individuelles, de sorte que la question d’un choix étayé entre HFC et HDI reste difficile.
Preview
Unable to display preview. Download preview PDF.
Références
Kramer P, Wigger W, Rieger J, Matthaei D, Scheler F (1977) Arteriovenous haemofiltration: A new and simple method for treatment of over-hydrated patients resistant to diuretics. Klin Wochenschr 55: 1121–2
Journois D, Safran D (1991) Continuous hemofiltration: An extrarenal filtration method used in intensive care. Ann Fr Anesth Réanim 10: 379–89
Bellomo R, Parkin G, Love J, Boyce N (1992) Use of continuous haemodiafiltration: An approach to the management of acute renal failure in the critically ill. Am J Nephrol 12: 240–5
Brunet S, Leblanc M, Geadah D, Parent D, Courteau S, Cardinal J (1999) Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 34: 486–92
Marshall MR, Golper TA, Shaver MJ, Alam MG, Chatoth DK (2001) Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int 60: 777–85
Marshall MR, Ma T, Galler D, Rankin AP, Williams AB (2004) Sustained low-efficiency daily diafiltration (sledd-f) for critically ill patients requiring renal replacement therapy: Towards an adequate therapy. Nephrol Dial Transplant 19: 877–84
Wu VC, Wang CH, Wang WJ et al. (2010) Sustained low-efficiency dialysis versus continuous veno-venous hemofiltration for postsurgical acute renal failure. Am J Surg 199: 466–76
Liao Z, Zhang W, Hardy PA et al. (2003) Kinetic comparison of different acute dialysis therapies. Artif Organs 27: 802–7
Berbece AN, Richardson RM (2006) Sustained low-efficiency dialysis in the icu: Cost, anticoagulation, and solute removal. Kidney Int 70: 963–8
Gomez A, Wang R, Unruh H et al. (1990) Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 73: 671–85
Journois D, Pouard P, Greeley WJ, Mauriat P, Vouhe P, Safran D (1994) Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Effects on hemostasis, cytokines, and complement components. Anesthesiology 81: 1181–9; discussion 1126A-1127A
Journois D, Israel-Biet D, Pouard P et al. (1996) High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology 85: 965–76
Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J (2002) Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial. Crit Care Med 30: 2205–11
Honore PM, Jamez J, Wauthier M et al. (2000) Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28: 3581–7
Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P (2001) High-volume haemofiltration in human septic shock. Intensive Care Med 27: 978–86
Leypoldt JK, Frigon RP, Henderson LW (1983) Dextran sieving coefficients of hemofiltration membranes. Trans Am Soc Artif Intern Organs 29: 678–83
Hakim RM, Wingard RL, Parker RA (1994) Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 331: 1338–42
Schiffl H, Lang SM, Konig A, Strasser T, Haider MC, Held E (1994) Biocompatible membranes in acute renal failure: Prospective case-controlled study. Lancet 344: 570–2
Canaud B, Martin K, Nguessan C, Klouche K, Leray-Loragues H, Beraud JJ (2001) Vascular access for extracorporeal renal replacement therapies in the intensive care unit in clinical practice. Contrib Nephrol 132: 266–22
van de Wetering J, Westendorp RG, van der Hoeven JG, Stolk B, Feuth JD, Chang PC (1996) Heparin use in continuous renal replacement procedures: The struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 7: 145–50
Journois D, Chanu D, Pouard P, Mauriat P, Safran D (1990) Assessment of standardized ultrafiltrate production rate using prostacyclin in continuous venovenous hemofiltration. In: H.G. S, H. M, K. SH, eds. Continuous hemofiltration. Basel, Karger: 202–4
Hory B, Cachoux A, Toulemonde F (1985) Continuous arteriovenous hemofiltration with low-molecular-weight heparin. Nephron 41: 125
Reeves JH, Cumming AR, Gallagher L, O’Brien JL, Santamaria JD (1999) A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration. Crit Care Med 27: 2224–8
Joannidis M, Kountchev J, Rauchenzauner M et al. (2007) Enoxaparin vs. Unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: A randomized controlled crossover study. Intensive Care Med 33: 1571–9
Sagedal S, Hartmann A, Osnes K et al. (2006) Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin. Nephrol Dial Transplant 21: 444–9
Tan HK, Baldwin I, Bellomo R (2000) Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med 26: 1652–7
Kramer L, Bauer E, Joukhadar C et al. (2003) Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 31: 2450–5
Morita Y, Johnson RW, Dorn RE, Hall DS (1961) Regional anticoagulation during hemodialysis using citrate. Am J Med Sci 242: 32–43
Mehta RL, McDonald BR, Aguilar MM, Ward DM (1990) Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38: 976–81
Palsson R, Niles JL (1999) Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 55: 1991–7
Morgera S, Schneider M, Slowinski T et al. (2009) A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med 37: 2018–24
Oudemans-van Straaten HM, Bosman RJ, Koopmans M et al. (2009) Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 37: 545–52
Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P (2004) Citrate vs. Heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study. Intensive Care Med 30: 260–5
Hofbauer R, Moser D, Frass M et al. (1999) Effect of anticoagulation on blood membrane interactions during hemodialysis. Kidney Int 56: 1578–83
Schortgen F, Soubrier N, Delclaux C et al. (2000) Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: Usefulness of practice guidelines. Am J Respir Crit Care Med 162: 197–202
Bellomo R, Martin H, Parkin G, Love J, Kearley Y, Boyce N (1991) Continuous arteriovenous haemodiafiltration in the critically ill: Influence on major nutrient balances. Intensive Care Med 17: 399–402
Schetz M (1997) Drug removal with continous renal replacement therapies. In: Journois D, ed. Continuous hemofiltration in the intensive care unit. Amsterdam, OPA: 69–77
Golper TA, Wedel SK, Kaplan AA, Saad AM, Donta ST, Paganini EP (1985) Drug removal during continuous arteriovenous hemofiltration: Theory and clinical observations. Int J Artif Organs 8: 307–12
Mehta RL, McDonald B, Gabbai FB et al. (2001) A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 60: 1154–63
Augustine JJ, Sandy D, Seifert TH, Paganini EP (2004) A randomized controlled trial comparing intermittent with continuous dialysis in patients with arf. Am J Kidney Dis 44: 1000–7
Lins RL, Elseviers MM, Van der Niepen P et al. (2009) Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: Results of a randomized clinical trial. Nephrol Dial Transplant 24: 512–8
Uehlinger DE, Jakob SM, Ferrari P et al. (2005) Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant 20: 1630–7
Vinsonneau C, Camus C, Combes A et al. (2006) Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: A multicentre randomised trial. Lancet 368: 379–85
Bagshaw SM, Berthiaume LR, Delaney A, Bellomo R (2008) Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: A meta-analysis. Crit Care Med 36: 610–7
Ronco C, Bellomo R, Homel P et al. (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 356: 26–30
Monti G, Herrera M, Kindgen-Milles D et al. (2007) The dose response multicentre international collaborative initiative (do-re-mi). Contrib Nephrol 156: 434–43
Brause M, Neumann A, Schumacher T, Grabensee B, Heering P (2003) Effect of filtration volume of continuous venovenous hemofiltration in the treatment of patients with acute renal failure in intensive care units. Crit Care Med 31: 841–6
Schiffl H, Lang SM, Fischer R (2002) Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346: 305–10
Saudan P, Niederberger M, De Seigneux S et al. (2006) Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 70: 1312–7
Palevsky PM, Zhang JH, O’Connor TZ et al. (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359: 7–20
Bellomo R, Cass A, Cole L et al. (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361: 1627–38
Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R (2003) Continuous is not continuous: The incidence and impact of circuit «down-time» on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 29: 575–8
Honore PM, Joannes-Boyau O, Collin V, Boer W, Gressens B, Janvier G (2008) Gestion pratique de l’épuration extrarénale continue au quotidien. Réanimation 17: 472–7
Bellomo R, Ronco C (1999) Renal replacement therapy in the intensive care unit. Crit Care Resusc 1: 13–24
Piccinni P, Dan M, Barbacini S et al. (2006) Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 32: 80–6
Cole L, Bellomo R, Hart G et al. (2002) A phase ii randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 30: 100–6
Rights and permissions
Copyright information
© 2011 Springer-Verlag France
About this chapter
Cite this chapter
Chhor, V., Journois, D. (2011). Techniques de suppléance de l’insuffisance rénale aiguë. In: Désordres métaboliques et réanimation. Le point sur .... Springer, Paris. https://doi.org/10.1007/978-2-287-99027-4_10
Download citation
DOI: https://doi.org/10.1007/978-2-287-99027-4_10
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-99026-7
Online ISBN: 978-2-287-99027-4
eBook Packages: MedicineMedicine (R0)